SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

AstraZeneca applies for COVID-19 vaccine approval in Japan

· 02/05/2021 01:03
AstraZeneca applies for COVID-19 vaccine approval in Japan

- AstraZeneca AZN.L said on Friday it had applied for approval in Japan for its COVID-19 vaccine, making it the second drug maker to do so after Pfizer Inc PFE.N.

The Japanese government in December signed a contract to procure 120 million doses of AstraZeneca vaccine, enough for 60 million people.


(Reporting by Kiyoshi Takenaka; Editing by Tom Hogue)

((kiyoshi.takenaka@thomsonreuters.com; +81 3 4563 2788;))